Covid-19 idiopathic pulmonary fibrosis impact largely logistical rather than clinical

One clear long-term impact of Covid-19 on clinical trials is the increased use of telemedicine to see patients more safely and more efficiently in the future.

Source: Covid-19 idiopathic pulmonary fibrosis impact largely logistical rather than clinical